2008 - Review: Individual DMARDs have similar efficacy for rheumatoid arthritis, but combination therapy improves response

Rothschild, Bruce M.
May 2008
ACP Journal Club;5/20/2008, Vol. 148 Issue 3, p4
Academic Journal
Case Study
The article presents information on a case study that was conducted to assess the relative benefits and harms of various disease-modifying antirheumatic drugs in adults with rheumatoid arthritis (RA). About hundred adults with RA were included in the study. The study found no clinical differences in efficacy or harm among or between synthetic and biological disease-modifying antirheumatic drugs.


Related Articles

  • The efficacy and safety of bucillamine as a second-line DMARD in the treatment of rheumatoid arthritis: a retrospective cohort study. Suda, Akiko; Nagaoka, Shouhei; Ohono, Shigeru; Ideguchi, Haruko; Soga, Takayoshi; Ishigatsubo, Yoshiaki // Modern Rheumatology (Springer Science & Business Media B.V.);Dec2008, Vol. 18 Issue 6, p609 

    We investigated the efficacy and safety of bucillamine administered as a second-line DMARD compared to administration as a first-line DMARD in the treatment of rheumatoid arthritis (RA). We conducted a retrospective cohort study and reviewed medical records of 86 patients with active RA who...

  • Have traditional DMARDs had their day? Rau, Rolf // Clinical Rheumatology;Jun2005, Vol. 24 Issue 3, p189 

    This review tries to answer the question of whether in the face of the recently introduced biologics conventional disease-modifying antirheumatic drugs (DMARDs) can still be recommended in the treatment of rheumatoid arthritis (RA). We start with an overview of the oldest conventional DMARD,...

  • Prevalence of and predictive factors for sustained diseasemodifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts.  // International Journal of Advances in Rheumatology;2009, Vol. 7 Issue 4, p126 

    This study of two cohorts of rheumatoid arthritis (RA) patients revealed that up to 15% of those who were treated with conventional therapy (disease-modifying anti-rheumatic drugs [DMARDs] or nonsteroidal antiinflammatory drugs) had sustained DMARD-free remission. Furthermore, this remission...

  • PHARMACOECONOMIC STUDY OF DMARDS IN THE MANAGEMENT OF RHEUMATOID ARTHRITIS. Shini, V. K.; Aboobacker, Shameena; Pahuja, Sudeepti; Revikumar, K. G.; Bhasi, Remesh // International Journal of Pharmaceutical Sciences Review & Resear;Nov2010, Vol. 5 Issue 3, p148 

    Rheumatoid arthritis (RA), being destructive to the joints, imposes considerable disease burden and is associated with major socio-economic implications to the affected population. The treatment cost varies depending on the medicines used, like, a comparatively cheaper Disease Modifying Anti...

  • Hemophagocytic syndrome in adult-onset Still's disease (AOSD): A must for biologics?-Case report and brief review of the literature. Bürgi, Urs; Mendez, Adriana; Hasler, Paul; Hüllstrung, Hans // Rheumatology International;Oct2012, Vol. 32 Issue 10, p3269 

    A case of adult-onset Still's disease complicated by hemophagocytic lymphohistiocytosis is reported. Its management is being discussed on the background of the latest literature with special regard on the use of high-dose corticosteroids and immunosuppressive agents.

  • A case of rheumatoid arthritis presenting with postherpetic neuralgia and abdominal-wall pseudohernia. Dobrev, Hristo; Atanassova, Penka; Sirakov, Vladimir; Zisova, Lilia // Rheumatology International;Jun2012, Vol. 32 Issue 6, p1775 

    Postherpetic neuralgia is a common complication, while the postherpetic abdominal-wall pseudohernia (AWP) is a quite rare complication of herpes zoster (HZ). We report a patient >45 years of age with a history of rheumatoid arthritis (RA) who presented with two chronic HZ complications. A...

  • Does tocilizumab contribute to elevation of rheumatoid factor and induction of paradoxical syaloadenitis in rheumatoid arthritis patients? Martinović Kaliterna, Dušanka; Aljinović, Jure; Perković, Dijana; Marasović Krstulović, Daniela; Marinović, Ivanka; Vlak, Tonko // Wiener Klinische Wochenschrift;Feb2014, Vol. 126 Issue 3/4, p126 

    A 56-year-old woman, treated with tocilizumab (TCZ) for 8 months for severe rheumatoid arthritis (RA), was admitted to the hospital due to the swelling and tenderness of parotid glands. The patient was diagnosed with seropositive erosive RA in 1988, and treated with different disease modifying...

  • Infliximab.  // Reactions Weekly;7/5/2008, Issue 1209, p19 

    The article describes the case of a 54-year-old woman who experienced pericarditis while receiving infliximab for rheumatoid arthritis. Results of laboratory investigation and echocardiogram are presented. He was treated with vancomycin and penicillins, but received clindamycin following the...

  • Association Between the Initiation of Anti-Tumor Necrosis Factor Therapy and the Risk of Herpes Zoster. Winthrop, Kevin L.; Baddley, John W.; Chen, Lang; Liu, Liyan; Grijalva, Carlos G.; Delzell, Elizabeth; Beukelman, Timothy; Patkar, Nivedita M.; Xie, Fenglong; Saag, Kenneth G.; Herrinton, Lisa J.; Solomon, Daniel H.; Lewis, James D.; Curtis, Jeffrey R. // JAMA: Journal of the American Medical Association;3/6/2013, Vol. 309 Issue 9, p887 

    The article focuses on a research that was conducted to investigate the association of initiation of anti-tumor necrosis factor (TNF) therapy with increased herpes zoster risk. It compared herpes zoster incidence between new anti-TNF users and patients initiating nonbiologic disease-modifying...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics